Information
HippoScreen Neurotech focuses on brainwave signal processing and artificial intelligence technology to develop innovative medical services for brainwave-assisted diagnosis and assessment. Their vision is to promote early detection and treatment to enhance public mental and brain health. Their brainwave device has received FDA 510(k) clearance in the United States and a medical device license from the Ministry of Health and Welfare, making them the first domestic manufacturer of medical-grade brainwave devices. They have also obtained ISO 13485 certification and a BSI certificate.
The first product, the "Stress EEG Assessment System," was developed by collecting clinical data from three major hospitals for depression and received a Software as Medical Device (SaMD) license in October 2023. The system combines a brainwave device, graphical interface, and AI algorithms to capture and analyze brainwave data in a relaxed state within 2 minutes via the cloud, providing an objective SEA score (1-10) indicating the probability of depression. It helps doctors explain and enhance patients' awareness and treatment compliance, and can be used as a mental health screening tool in enterprises and communities.
Key Advantages:
- The world's first EEG system approved by regulatory authorities to assist in diagnosing depression.
- Clinical evidence: Collaborated with three major medical centers, enrolling over 400 participants and verifying accuracy, with results published in multiple international journals.
- Safe and convenient: Non-invasive, radiation-free, 8-channel electrodes, easy and quick to operate. The test is completed in 15 minutes with immediate results.
Initially, the company aims to establish its brand professionalism with medical products, then expand to explore applications such as corporate EAP and mental health screening. In addition to entering the medical system, they will also cultivate the health prevention market, providing objective and quantitative assessment indices, making it an important AI assistant for mental and brain health screening.
Benefits
The SEA system is an efficient brainwave detection tool that can provide an objective depression assessment report within 15 minutes. For patients lacking insight into their condition, this physiological test offers strong evidence, helping doctors explain depression as a "cold of the brain," significantly enhancing patients' awareness and treatment compliance.
In the corporate setting, the SEA test can serve as an employee benefit, allowing employees who are worried but reluctant to seek counseling or medical treatment to understand their mental state. This aids in the early detection and prevention of issues, ensuring employee productivity and improving overall mental health. The application of the SEA system not only protects the company's most valuable asset—its employees—but also promotes the enhancement of public mental health.
Success Stories
1. 19th Natioanl Innovation Award
2. 2024 Taiwan BIO Award
3. 2025 Symbol of National Quality
National/International Medical Device Legal Permit No.
8-CH Electroencephalography Amplifier
510(K) number: K201747
